Recent Quotes
My Watchlist
Indicators
EL&P Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Moderna, Inc. - Common Stock (NQ:MRNA)

32.61 -0.05 (-0.15%)
Streaming Delayed Price Updated: 10:10 AM EDT, Jul 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Moderna, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Oscar Health, Surgery Partners, Moderna, Molina Healthcare, and Fortrea Stocks Trade Down, What You Need To Know
A number of stocks fell in the afternoon session after industry bellwether UnitedHealth Group (UNH) slashed its 2025 profit forecast after reporting a significant surge in medical costs, sending... 
Via StockStory
Uncover the latest developments among S&P500 stocks in today's session.
Stay informed about the performance of the S&P500 index in the middle of the day on Tuesday. Uncover the top gainers and losers in today's session for valuable insights. 
Via Chartmill
Robert Kennedy Jr Blasts Vaccine Injury Compensation Program: 'Devolved Into A Morass Of Inefficiency, Favoritism, And Outright Corruption'
Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. is pledging a major overhaul of the National Vaccine Injury Compensation Program (VICP), describing the system as fundamentally broken... 
Via Benzinga
Moderna Announces Data to be Presented at ESMO Congress 2025
Via ACCESS Newswire
Down 74% Over the Past Year, Is Moderna Stock a Buy?
Via The Motley Fool
Biotech Is Booming, and This Undervalued REIT Stands to Gain
Via The Motley Fool
EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna's COVID-19 mRNA Vaccine Targeting the SARS-CoV-2 Variant LP.8.1
Via ACCESS Newswire
What's Going On With Moderna Stock Wednesday?
Moderna stock rises on flu vaccine data and FDA approvals, while healthcare stocks remain under pressure amid political uncertainty. 
Via Benzinga
Which S&P500 stocks are moving on Wednesday?
Let's delve into the developments on the US markets one hour before the close of the markets on Wednesday. Below, you'll find the top gainers and losers within the S&P500 index during today's session. 
Via Chartmill
Uncover the latest developments among S&P500 stocks in today's session.
Curious about the top performers within the S&P500 index in the middle of the day on Wednesday? Dive into the list of today's session's top gainers and losers for a comprehensive overview. 
Via Chartmill
Wednesday's session: gap up and gap down stock in the S&P500 index
Let's have a look at what is happening on the US markets on Wednesday. Below you can find the S&P500 gap up and gap down stocks in today's session. 
Via Chartmill
Moderna, Lantheus, Centene, AMN Healthcare Services, and NeoGenomics Shares Plummet, What You Need To Know
A number of healthcare stocks fell in the afternoon session after several negative developments weighed on the sector. Weakness in managed care providers was a significant factor, with companies like... 
Via StockStory
Topics Lawsuit World Trade
3 of Wall Street’s Favorite Stocks That Fall Short
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings,... 
Via StockStory
Reflecting On Therapeutics Stocks’ Q1 Earnings: Moderna (NASDAQ:MRNA)
As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the therapeutics industry, including Moderna (NASDAQ:MRNA) and its peers. 
Via StockStory
Topics Artificial Intelligence
Uncover the latest developments among S&P500 stocks in today's session.
Curious about the top performers within the S&P500 index one hour before the close of the markets on Tuesday? Dive into the list of today's session's top gainers and losers for a comprehensive... 
Via Chartmill
GSK Seeks FDA Nod To Broaden RSV Vaccine For Younger At-Risk Adults
FDA accepts GSK's application to expand Arexvy vaccine use to at-risk adults aged 18–49, with a decision expected in the first half of 2026. 
Via Benzinga
Opinion: It's Time to Load Up on This Biotech Giant After Its 80% Crash
Via The Motley Fool
Why Moderna (MRNA) Stock Is Falling Today
Shares of biotechnology company Moderna (NASDAQ:MRNA) fell 3.6% in the morning session after JPMorgan added the stock to its list of top short ideas for the second half of 2025. 
Via StockStory
Topics ETFs Stocks World Trade
Delta Air, Moderna And Coinbase Are Among Top Large Cap Gainers Last Week (July 7-July 11): Are The Others In Your Portfolio?
Top performers last week: Venture Global up 18.96% on LNG deal, SoFi up 14.29% on analyst coverage, Delta up 11.91% on earnings, Unity up 9.17% on price forecast, Moderna up 10.66% on FDA approval, PTC... 
Via Benzinga
U.S. Physical Therapy, Evolent Health, Charles River Laboratories, Moderna, and Intuitive Surgical Shares Are Falling, What You Need To Know
A number of stocks fell in the morning session after the U.S. administration announced a sharp escalation in trade tensions by threatening new tariffs on Canada. 
Via StockStory
Topics ETFs Stocks World Trade
What's Driving the Market Sentiment Around Moderna?
 
Via Benzinga
2 Stocks Under $50 on Our Watchlist and 1 to Ignore
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to... 
Via StockStory
FDA Grants Complete Approval To Moderna's COVID-19 Vaccine For Children As Young As 6 Months
Moderna's Spikevax receives FDA approval for use in high-risk children; Pfizer, BioNTech appeal U.K. ruling in COVID-19 vaccine patent dispute. 
Via Benzinga
Topics Intellectual Property
Should Politicians Be Allowed to Trade Stocks? The Big Debate
A growing chorus of lawmakers, ethics watchdogs, and concerned citizens are reigniting a high-stakes debate: Should U.S. politicians be allowed to buy and sell stocks while in office? Amidst rising... 
Via MarketMinute
Topics Artificial Intelligence Electric Vehicles
Why Moderna (MRNA) Stock Is Up Today
Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 3.8% in the morning session after the U.S. Food and Drug Administration (FDA) granted full approval for its Spikevax COVID-19 vaccine to be... 
Via StockStory
Topics Artificial Intelligence
Moderna’s Covid Vaccine Gets Full FDA Approval For Use In Children 6 Months And Older
The vaccine was previously available for pediatric populations under Emergency Use Authorization only. 
Via Stocktwits
Market Monitor News July 09 BMO (Moderna & Merit Medical System UP - Solar & Bank Stocks DOWN)
Wall Street Holds Its Breath: Tariff Tantrums, Solar Slaps, and a Surge from Moderna 
Via Chartmill
Top S&P500 movers in Tuesday's session
Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Tuesday. 
Via Chartmill
Medical Groups Sue RFK Jr. For Assault On Science Over Unlawful COVID-19 Vaccine Rollbacks
Major health groups sue HHS and Robert F. Kennedy Jr. over COVID-19 vaccine policy changes for children and pregnant individuals. 
Via Benzinga
Discover which S&P500 stocks are making waves on Tuesday.
Let's have a look at what is happening on the US markets in the middle of the day on Tuesday. Below you can find the top S&P500 gainers and losers in today's session. 
Via Chartmill
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.